Yale Researchers Develop New Testing Criteria for Hereditary Stomach Cancer
Yale researchers have shown that individuals who carry a mutation in the CDH1 gene have a 30% to 40% risk of developing stomach cancer during their lifetime. Yet many people with the rare inherited condition remain unaware that they have it.
Trevor Sorrells appointed HHMI Freeman Hrabowski Scholar
Trevor Sorrells, PhD, Assistant Professor and researcher at Yale School of Medicine, was recently named an inaugural Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholar. This program celebrates and supports scientists with the potential to become great leaders in their field and create a more diverse and inclusive scientific environment.
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities
In my opinion, one of the greatest advances in oncology has been the discovery of cancer genes that can provide information about hereditary cancer risk and guide cancer screening and treatment. Indeed, 5-15% of patients with cancer have inheritedopens in a new tab or window genetic mutations. Let's put this in context.Source: MedPage Today
Dr. Raman Nelakanti Awarded the 2023 Slayman Prize in Genetics
The Carolyn Slayman prize, awarded each year by the Department of Genetics, recognizes not only achievement in scientific research but also exceptional contributions to the scientific community. This year’s recipient is Dr. Raman Nelakanti, a geneticist who recently obtained his MD-PhD from the School of Medicine.
How genetics determine our life choices
It has been 20 years since the Human Genome Project was "completed". But it quickly became apparent that the efforts to sequence and map the human "book of life" was only just the beginning. Far from closing the question of what makes our bodies tick and why they do so differently, research on the human genome has revealed a far more complex picture than anyone could have imagined. We may not realize it, but it appears that many routine aspects of our daily lives might be partially driven by our genome.Source: BBC.com
Researchers explore the role of cellular plasticity in cancer
A recently published Yale study explored how cancer cell plasticity — which refers to the ability of cells to adapt their phenotypes in response to environmental signals without undergoing genetic alterations — might impact the development, progression and treatment of cancer.Source: Yale Daily News
Multidisciplinary COPPER Center Brings a Public Health Lens to Cancer Care
Studying cancer treatment outcomes is the mission of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, a collaborative effort of the Yale Cancer Center and the Schools of Medicine and Public Health.Source: Yale Public Health magazine